95 Publications (Page 2 of 4)
2013
Characterization of vaniprevir, a hepatitis C virus NS3/4A protease inhibitor, in patients with HCV genotype 1 infection: safety, antiviral activity, resistance, and pharmacokinetics.
Lawitz, EricLawitz, EricSulkowski, MarkSulkowski, Mark SJacobson, Ira MJacobson, IraKraft, Walter KKraft, Walter KMaliakkal, BenedictMaliakkal, BenedictAl-Ibrahim, MohamedAl-Ibrahim, MohamedGordon, Stuart CGordon, Stuart CKwo, PaulKwo, PaulRockstroh, Juergen KRockstroh, Juergen KurtPanorchan, PaulPanorchan, PaulMiller, MichelleMiller, MichelleCaro, LuzelenaCaro, LuzelenaBarnard, RichardBarnard, RichardHwang, Peggy MayHwang, Peggy MGress, JacquelineGress, JacquelineQuirk, ErinQuirk, ErinMobashery, Niloufar and Mobashery, Niloufar
Antiviral research, vol. 99, (no. 3), pp. 214-20, 2013/Sep. | Journal Article
 
De novo malignancy post-liver transplantation: a single center, population controlled study.
Chatrath, HemantBerman, KennethVuppalanchi, RajSlaven, JamesKwo, PaulTector, A JosephChalasani, Naga and Ghabril, Marwan
Clinical transplantation, vol. 27, (no. 4), pp. 582-590. | Journal Article
 
IDX184 in combination with pegylated interferon-α2a and ribavirin for 2 weeks in treatment-naive patients with chronic hepatitis C.
Lalezari, JacobLalezari, JacobBox, TerryBox, TerryO'Riordan, WilliamO'Riordan, WilliamMehra, PurviMehra, PurviNguyen, TuanNguyen, TuanPoordad, FredPoordad, FredDejesus, EdwinDeJesus, EdwinKwo, PaulKwo, PaulGodofsky, EliotGodofsky, EliotLawrence, ShannonLawrence, ShannonDubuc-Patrick, GloriaDubuc-Patrick, GloriaChen, JieChen, JieMcCarville, JosephMcCarville, JosephPietropaolo, KeithPietropaolo, KeithZhou, Xiao-JianZhou, Xiao-JianSullivan-Bólyai, JohnSullivan-Bólyai, JohnMayers, Douglas and Mayers, Douglas
Antiviral therapy, vol. 18, (no. 6), pp. 755-764, 2013. | Journal Article
 
Oral direct-acting antiviral therapy to prevent reinfection of the liver graft after liver transplantation for hepatitis C virus-related cirrhosis.
Kwo, Paul Y and Tector, A Joseph
(pp. 780-781). July 2013
 
Resistance-associated amino acid variants associated with boceprevir plus pegylated interferon-α2b and ribavirin in patients with chronic hepatitis C in the SPRINT-1 trial.
Ogert, Robert AHowe, John AVierling, John MKwo, Paul YLawitz, Eric JMcCone, JonathanSchiff, Eugene RPound, DavidDavis, Mitchell NGordon, Stuart CRavendhran, NatarajanRossaro, LorenzoJacobson, Ira MRalston, RobertChaudhri, EirumQiu, PingPedicone, Lisa DBrass, Clifford AAlbrecht, Janice KBarnard, Richard JHazuda, Daria J and Howe, Anita Y
Antiviral therapy, vol. 18, (no. 3), pp. 387-97, 2013. | Journal Article
 
The cost-effectiveness of birth cohort screening for hepatitis C antibody in US primary care settings.
Vuppalanchi, Raj and Kwo, Paul Y
Gastroenterology, vol. 144, (no. 2), pp. 457-459, February 2013. | Journal Article
2012
Anemia management in the era of triple combination therapy for chronic HCV.
Jacobson, Ira MKowdley, Kris V and Kwo, Paul Y
Gastroenterology & hepatology, vol. 8, (no. 9 Suppl 6), pp. 1-16, 2012/Sep. | Journal Article
 
Boceprevir: a novel nonstructural 3 (NS3) protease inhibitor for the treatment of chronic hepatitis C infection.
Kwo, Paul Y
Therapeutic advances in gastroenterology, vol. 5, (no. 3), pp. 179-188, May 2012. | Journal Article
 
Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients.
Thompson, AlexanderThompson, A.J.Clark, P.J.Clark, Paul JSingh, A.Singh, AbanishGe, DongliangGe, D.Fellay, JacquesFellay, J.Zhu, M.Zhu, MingfuZhu, QianqianZhu, Q.Urban, ThomasUrban, T.J.Patel, K.Patel, KeyurTillmann, H.L.Tillmann, Hans LNaggie, S.Naggie, SusannaAfdhal, Nezam HAfdhal, N.H.Jacobson, Ira MJacobson, I.M.Esteban, R.Esteban, RafaelPoordad, F.Poordad, FredLawitz, Eric JLawitz, E.J.McCone, J.McCone, JonathanShiffman, Mitchell LShiffman, M.L.Galler, Greg WGaller, G.W.King, John WKing, J.W.Kwo, P.Y.Kwo, Paul YShianna, KevinShianna, K.V.Noviello, StephanieNoviello, S.Pedicone, L.D.Pedicone, Lisa DBrass, C.A.Brass, Clifford AAlbrecht, Janice KAlbrecht, J.K.Sulkowski, Mark SSulkowski, M.S.Goldstein, D.B.Goldstein, David BMc Hutchison, John GMcHutchison, J.G.Muir, A.J. and Muir, Andrew J
Journal of hepatology, vol. 56, (no. 2), pp. 313-9, 2012/Feb. | Journal Article
 
Immunosuppression induction with rabbit anti-thymocyte globulin with or without rituximab in 1000 liver transplant patients with long-term follow-up.
Mangus, Richard SFridell, Jonathan AVianna, Rodrigo MKwo, Paul YChen, Jeanne and Tector, A J
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, vol. 18, (no. 7), pp. 786-95, 2012/Jul. | Journal Article
 
Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response.
Clark, P JClark, P. J.Thompson, A JThompson, A. J.Zhu, M.Zhu, MVock, D. M.Vock, David MZhu, QianqianZhu, Q.Ge, D.Ge, DongliangPatel, K.Patel, KHarrison, S. A.Harrison, S AUrban, ThomasUrban, T. J.Naggie, S.Naggie, SusannaFellay, J.Fellay, JTillmann, H. L.Tillmann, H LShianna, KevinShianna, K.Noviello, S.Noviello, SPedicone, L. D.Pedicone, L DEsteban, REsteban, R.Kwo, Paul YKwo, P.Sulkowski, Mark SSulkowski, M. S.Afdhal, N.Afdhal, Nezam HAlbrecht, J KAlbrecht, J. K.Goldstein, David BGoldstein, D. B.Mc Hutchison, John GMcHutchison, J. G.Muir, Andrew JMuir, A. J. and Investigators, Ideal
Journal of viral hepatitis, vol. 19, (no. 5), pp. 332-40, 2012/May. | Journal Article
 
Multisociety sedation curriculum for gastrointestinal endoscopy.
Vargo, John JDeLegge, Mark HFeld, Andrew DGerstenberger, Patrick DKwo, Paul YLightdale, Jenifer RNuccio, SusanRex, Douglas K and Schiller, Lawrence R
Gastroenterology, vol. 143, (no. 1), pp. e18-41, 2012/Jul. | Journal Article
 
Multisociety sedation curriculum for gastrointestinal endoscopy.
Vargo, John JDeLegge, Mark HFeld, Andrew DGerstenberger, Patrick DKwo, Paul YLightdale, Jenifer RNuccio, SusanRex, Douglas K and Schiller, Lawrence R
Gastrointestinal endoscopy, vol. 76, (no. 1), pp. e1-25, 2012/Jul. | Journal Article
 
Multisociety Sedation Curriculum for Gastrointestinal Endoscopy.
Vargo, John JDelegge, Mark HFeld, Andrew DGerstenberger, Patrick DKwo, Paul YLightdale, Jenifer RNuccio, SusanRex, Douglas K and Schiller, Lawrence R
The American journal of gastroenterology, May 22, 2012. | Journal Article
 
Peginterferon-α-2b and ribavirin for hepatitis C recurrence postorthotopic liver transplantation.
Gordon, Fredric DKwo, PaulGhalib, ReemCrippin, Jeffrey SVargas, Hugo EBrown, Kimberly ASchiano, ThomasChaudhri, EirumPedicone, Lisa D and Brown, Robert S
Journal of clinical gastroenterology, vol. 46, (no. 8), pp. 700-8, 2012/Sep. | Journal Article
 
Phase III results in Genotype 1 naïve patients: predictors of response with boceprevir and telaprevir combined with pegylated interferon and ribavirin.
Kwo, Paul Y
Liver international : official journal of the International Association for the Study of the Liver, vol. 32 Suppl 1, pp. 39-43, 2012/Feb. | Journal Article
 
Shortness of breath in the patient with chronic liver disease.
Kwo, Paul Y
Clinics in liver disease, vol. 16, (no. 2), pp. 321-9, 2012/May. | Journal Article
2011
A glimpse at the future of hepatitis C therapy: the INFORM trial.
Lim, Lei Y and Kwo, Paul Y
Hepatology (Baltimore, Md.), vol. 54, (no. 1), pp. 360-3, 2011/Jul. | Journal Article
 
Boceprevir.
Maddur, Haripriya and Kwo, Paul Y
Hepatology (Baltimore, Md.), vol. 54, (no. 6), pp. 2254-2257, December 2011. | Journal Article
 
Boceprevir: a user's guide.
Kwo, Paul Y and Zhao, Rong
Clinics in liver disease, vol. 15, (no. 3), pp. 537-53, 2011/Aug. | Journal Article
 
Diffusion-weighted MRI of the transplanted liver.
Sandrasegaran, KumaresanRamaswamy, RGhosh, STahir, BAkisik, F MSaxena, R and Kwo, Paul Y
Clinical radiology, vol. 66, (no. 9), pp. 820-5, 2011/Sep. | Journal Article
 
Hepatic and extrahepatic cancer in cirrhosis: a longitudinal cohort study.
Berman, KennethTandra, SwetaVuppalanch, RajGhabril, MarwanSandrasegaran, KumaresanNguyen, JamesCaffrey, HelenaLiangpunsakul, SuthatLumeng, LawrenceKwo, Paul Y and Chalasani, Naga
The American journal of gastroenterology, vol. 106, (no. 7), pp. 1405, 2011/Jul. | Journal Article
 
Hepatic and extrahepatic cancer in cirrhosis: a longitudinal cohort study.
Berman, KennethTandra, SwetaVuppalanch, RajVuppalanchi, Raj KGhabril, Marwan SVuppalanch, RajSandrasegaran, KumaresanGhabril, MarwanNguyen, JamesSandrasegaran, KumaresanNguyen, JamesCaffrey, HelenaCaffrey, HelenaLiangpunsakul, SuthatLiangpunsakul, SuthatLumeng, LawrenceLumeng, LawrenceKwo, Paul YChalasani, NagaKwo, Paul and Chalasani, Naga
The American journal of gastroenterology, vol. 106, (no. 5), pp. 899-906, 2011/May. | Journal Article
 
Incidence and predictors of 30-day readmission among patients hospitalized for advanced liver disease.
Berman, KennethTandra, SwetaForssell, KateVuppalanchi, Raj KVuppalanch, RajBurton, James RNguyen, JamesBurton, James RNguyen, JamesMullis, DevonneKwo, Paul YMullis, DevonneChalasani, NagaKwo, Paul and Chalasani, Naga
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, vol. 9, (no. 3), pp. 254-9, 2011/Mar. | Journal Article
 
Response-guided therapy for HCV.
Kwo, Paul Y
Gastroenterology & hepatology, vol. 7, (no. 1), pp. 43-5, 2011/Jan. | Journal Article